Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic
The COVID-19 pandemic has stressed healthcare systems in the United States and globally. Limited hospital resources, increasing patient surge, and growing demands on healthcare providers have led to the United States Surgeon General and the Centers for Medicare & Medicaid Services calling for suspension of all nonessential adult elective surgery and medical procedures. As of March 27, 2020, 30 states had issued similar declarations related to elective procedures in the setting of the continuing COVID-19 pandemic. Two major questions have emerged as these events have unfolded: (1) What is the definition of an "elective" procedure? and (2) Are there specialty-specific considerations for obstetric and gynecologic procedures? This article provides insights into each of these questions and provides a working framework for obstetrician/gynecologists to advocate for their patients and coordinate with their hospital systems to develop "elective" procedure guidelines that incorporate considerations for women's and maternal health.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
The Journal of reproductive medicine - 66(2021), 2 vom: 01. Apr., Seite 59-66 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ramsey, Patrick S [VerfasserIn] |
|---|
| Anmerkungen: |
Date Revised 13.08.2022 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM34186577X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34186577X | ||
| 003 | DE-627 | ||
| 005 | 20231226012745.0 | ||
| 007 | tu | ||
| 008 | 231226s2021 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1139.xml |
| 035 | |a (DE-627)NLM34186577X | ||
| 035 | |a (NLM)35664692 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ramsey, Patrick S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 13.08.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The COVID-19 pandemic has stressed healthcare systems in the United States and globally. Limited hospital resources, increasing patient surge, and growing demands on healthcare providers have led to the United States Surgeon General and the Centers for Medicare & Medicaid Services calling for suspension of all nonessential adult elective surgery and medical procedures. As of March 27, 2020, 30 states had issued similar declarations related to elective procedures in the setting of the continuing COVID-19 pandemic. Two major questions have emerged as these events have unfolded: (1) What is the definition of an "elective" procedure? and (2) Are there specialty-specific considerations for obstetric and gynecologic procedures? This article provides insights into each of these questions and provides a working framework for obstetrician/gynecologists to advocate for their patients and coordinate with their hospital systems to develop "elective" procedure guidelines that incorporate considerations for women's and maternal health | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a COVID-19 pandemic | |
| 650 | 4 | |a SARS-COV-2 | |
| 650 | 4 | |a betacoronavirus | |
| 650 | 4 | |a coronavirus infections | |
| 650 | 4 | |a delivery of health care | |
| 650 | 4 | |a disease transmission | |
| 650 | 4 | |a elective procedure | |
| 650 | 4 | |a gynecology | |
| 650 | 4 | |a infectious/prevention & control | |
| 650 | 4 | |a obstetrics | |
| 650 | 4 | |a obstetrics and gynecology department, hospital | |
| 650 | 4 | |a pandemics | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a risk factors | |
| 700 | 1 | |a Page-Ramsey, Sarah M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of reproductive medicine |d 1970 |g 66(2021), 2 vom: 01. Apr., Seite 59-66 |w (DE-627)NLM000019577 |x 0024-7758 |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2021 |g number:2 |g day:01 |g month:04 |g pages:59-66 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 66 |j 2021 |e 2 |b 01 |c 04 |h 59-66 | ||